David E. Kuhl

Q: What Schools Are Affiliated With David E. Kuhl

David E. Kuhl is affiliated with the following schools: University of Michigan, University of California, Los Angeles

David E. Kuhl's AcademicInfluence.com Rankings

David E. Kuhl

Computer Science

#3817

World Rank

#4012

Historical Rank

Computer Graphics

#82

World Rank

#85

Historical Rank

Database

#1086

World Rank

#1143

Historical Rank

computer-science Degrees

David E. Kuhl

Physics

#3726

World Rank

#5233

Historical Rank

Nuclear Physics

#56

World Rank

#84

Historical Rank

physics Degrees

Download Badge

Computer Science
Physics

Why Is David E. Kuhl Influential?

(Suggest an Edit or Addition)

(See a Problem?)

David E. Kuhl's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method (1979) (1786)
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease (1997) (1671)
TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD (1980) (1197)
The [18F]Fluorodeoxyglucose Method for the Measurement of Local Cerebral Glucose Utilization in Mane (1979) (1139)
Noninvasive determination of local cerebral metabolic rate of glucose in man. (1980) (1034)
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. (1995) (1009)
Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. (1990) (568)
Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation (2001) (496)
Quantifying local cerebral blood flow by N-isopropyl-p-[123I]iodoamphetamine (IMP) tomography. (1982) (494)
Cerebral metabolism and atrophy in huntington's disease determined by 18FDG and computed tomographic scan (1982) (486)
Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3 (1980) (439)
N‐13 Ammonia as an Indicator of Myocardial Blood Flow (1981) (434)
Anatomic standardization: linear scaling and nonlinear warping of functional brain images. (1994) (423)
Image Separation Radioisotope Scanning (1963) (418)
Labeled 2-deoxy-D-glucose analogs. 18F-labeled 2-deoxy-2-fluoro-D-glucose, 2-deoxy-2-fluoro-D-mannose and 14C-2-deoxy-2-fluoro-D-glucose (1978) (410)
Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy (1982) (396)
Effects of stroke on local cerebral metabolism and perfusion: Mapping by emission computed tomography of 18FDG and 13NH3 (1980) (383)
The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia. (1983) (379)
In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease (1996) (369)
Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects (1981) (356)
Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes (1982) (351)
Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography (1991) (351)
Effects of Human Aging on Patterns of Local Cerebral Glucose Utilization Determined by the [18F] Fluorodeoxyglucose Method (1982) (349)
Tomographic mapping of human cerebral metabolism (1982) (348)
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer’s disease (1999) (336)
Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. (1987) (334)
Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging (1996) (308)
Correlation of criteria used for localizing epileptic foci in patients considered for surgical therapy of epilepsy (1981) (305)
ECAT: a new computerized tomographic imaging system for positron-emitting radiopharmaceuticals. (1978) (291)
Posterior cingulate cortex in Alzheimer's disease (1994) (275)
Quantitation in positron emission computed tomography: 2. Effects of inaccurate attenuation correction. (1979) (274)
Validation of tomographic measurement of cerebral blood volume with C-11-labeled carboxyhemoglobin. (1979) (274)
METABOLIC MAPPING OF THE BRAIN'S RESPONSE TO VISUAL STIMULATION: STUDIES IN HUMANS (1981) (272)
Automated detection of the intercommissural line for stereotactic localization of functional brain images. (1993) (271)
Patterns of human local cerebral glucose metabolism during epileptic seizures. (1982) (262)
Noninvasive assessment of coronary stenoses by myocardial imaging during pharmacologic coronary vasodilation. VI. Detection of coronary artery disease in human beings with intravenous N-13 ammonia and positron computed tomography. (1982) (258)
Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. (1978) (246)
Comparative localization of foci in partial epilepsy by PCT and EEG (1982) (241)
Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. (1991) (241)
Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. (1979) (239)
Radiopharmaceuticals XXVII. 18F-labeled 2-deoxy-2-fluoro-d-glucose as a radiopharmaceutical for measuring regional myocardial glucose metabolism in vivo: tissue distribution and imaging studies in animals. (1977) (233)
Quantitation in Positron Emission Computed Tomography: 4. Effect of Accidental Coincidences (1981) (231)
Tomographic mapping of human cerebral metabolism (1981) (223)
Local cerebral metabolism during partial seizures (1983) (220)
Tomographic mapping of human cerebral metabolism (1981) (218)
Preserved Pontine Glucose Metabolism in Alzheimer Disease: A Reference Region for Functional Brain Image (PET) Analysis (1995) (212)
Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains. (2001) (210)
Pathophysiology, treatment and outcome following severe head injury in children. (1979) (199)
C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C- 11 palmitic acid in normal myocardium. (1982) (198)
In vivo cerebral metabolism and central benzodiazepine‐receptor binding in temporal lobe epilepsy (1993) (194)
Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study (2011) (193)
Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method (1984) (193)
Quantifying Interictal Metabolic Activity in Human Temporal Lobe Epilepsy (1990) (178)
Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. (1997) (167)
PET Imaging of human gliomas with ligands for the peripheral benzodiazepine binding site (1989) (163)
PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. (1992) (163)
18FDG positron emission computed tomography in a study of aphasia (1981) (161)
Computed tomography of pediatric head trauma: acute general cerebral swelling. (1978) (157)
Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease (1984) (157)
Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression. (1986) (151)
The Mark IV system for radionuclide computed tomography of the brain. (1976) (150)
Effect of Ischemia on Quantification of Local Cerebral Glucose Metabolic Rate in Man (1981) (149)
Tomographic mapping of human cerebral metabolism: Sensory deprivation (1982) (143)
Motor correlates of occipital glucose hypometabolism in Parkinson’s disease without dementia (1999) (139)
Local Cerebral Blood Volume Response to Carbon Dioxide in Man (1978) (137)
Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. (1982) (134)
Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex (2000) (133)
Cerebral Metabolic Relationships for Selected Brain Regions in Healthy Adults (1984) (131)
In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. (1994) (130)
PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease. (1995) (128)
Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. (1996) (124)
Correlation methods for the centering, rotation, and alignment of functional brain images. (1990) (122)
A BOUNDARY METHOD FOR ATTENUATION CORRECTION IN POSITRON COMPUTED TOMOGRAPHY (1981) (121)
Measurement of local cerebral glucose metabolism in man with 18F-2-fluoro-2-deoxy-d-glucose. (1977) (119)
Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. (1996) (119)
Differentiation of Radioligand Delivery and Binding in the Brain: Validation of a Two-Compartment Model for [11C]Flumazenil (1991) (114)
Comparison of metabolic rates, language, and memory in subcortical aphasias (1983) (114)
Verbal Fluency and Positron Emission Tomographic Mapping of Regional Cerebral Glucose Metabolism (1992) (113)
Neuropsychological function and cerebral glucose utilization in isolated memory impairment and Alzheimer's disease. (1999) (112)
Parametric in vivo imaging of benzodiazepine receptor distribution in human brain (1991) (110)
Kinetic Modeling of N-[11C]Methylpiperidin-4-yl Propionate: Alternatives for Analysis of an Irreversible Positron Emission Tomography Tracer for Measurement of Acetylcholinesterase Activity in Human Brain (1999) (104)
Error Sensitivity of Fluorodeoxyglucose Method for Measurement of Cerebral Metabolic Rate of Glucose (1981) (104)
Kinetic Evaluation of [11C]Dihydrotetrabenazine by Dynamic PET: Measurement of Vesicular Monoamine Transporter (1996) (103)
[3H]methoxytetrabenazine: A high specific activity ligand for estimating monoaminergic neuronal integrity (1995) (103)
In vivo quantitation of regional myocardial blood flow by positron-emission computed tomography. (1981) (103)
CYLINDRICAL AND SECTION RADIOISOTOPE SCANNING OF THE LIVER AND BRAIN. (1964) (102)
Computed tomography of intracerebral hematomas. I. Transmission CT observations on hematoma resolution. (1977) (102)
Metabolic fate of [13N]ammonia in human and canine blood. (1990) (99)
Quantitative section scanning using orthogonal tangent correction. (1973) (99)
In vivo studies of acetylcholinesterase activity using a labeled substrate, N‐[11C]methylpiperdin‐4‐yl propionate ([11C]PMP) (1996) (96)
Remote, semiautomated production of F-18-labeled 2-deoxy-2-fluoro-D-glucose. (1981) (95)
Cerebral glucose metabolic patterns in Alzheimer's disease. Effect of gender and age at dementia onset. (1989) (94)
Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images. (1994) (91)
Cerebral Extraction of N‐13 Ammonia: Its Dependence on Cerebral Blood Flow and Capillary Permeability — Surface Area Product (1981) (88)
Equilibrium versus Compartmental Analysis for Assessment of the Vesicular Monoamine Transporter Using (+)-α-[11C]Dihydrotetrabenazine (DTBZ) and Positron Emission Tomography (1997) (87)
Positron emission tomographic evaluation of cerebral blood flow during state anxiety in simple phobia. (1989) (87)
[18F]fluoroethoxy‐benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses (1998) (85)
The effect of normal aging on patterns of local cerebral glucose utilization (1984) (85)
Decreased striatal monoaminergic terminals in Huntington disease (2000) (84)
LOCAL CEREBRAL BLOOD VOLUME IN HEAD‐INJURED PATIENTS. DETERMINATION BY EMISSION COMPUTED TOMOGRAPHY OF 99mTc‐LABELED RED CELLS (1980) (84)
Quantitation in Positron Emission Computed Tomography: 3. Effect of Sampling (1980) (84)
Cerebral Metabolic Relationships for Selected Brain Regions in Alzheimer's, Huntington's, and Parkinson's Diseases (1984) (83)
Integrated and automated data analysis method for neuronal activation studies using O-15 water PET (1993) (82)
Reorganizing data from transverse section scans of the brain using digital processing. (1968) (82)
Assessment of regional myocardial ischemia by positron-emission computed tomography. (1982) (79)
Probable diffuse Lewy body disease presenting as REM sleep behavior disorder (1997) (77)
Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease. (1995) (77)
Assessment of Extrastriatal Vesicular Monoamine Transporter Binding Site Density Using Stereoisomers of [11C]Dihydrotetrabenazine (1999) (77)
Electrocardiographic gating in positron emission computed tomography. (1979) (77)
Transmission scanning: a useful adjunct to conventional emission scanning for accurately keying isotope deposition to radiographic anatomy. (1966) (76)
Cerebral Glucose Metabolism as a Function of Age in Man: Influence of the Rate Constants in the Fluorodeoxyglucose Method (1983) (74)
Effects of long-term hormone therapy on cholinergic synaptic concentrations in healthy postmenopausal women. (2001) (70)
The effect of steroids on the extravascular distribution of radiographic contrast material and technetium pertechnetate in brain tumors as determined by computed tomography. (1976) (69)
In Vivo Imaging of Vesicular Monoamine Transporters in Human Brain Using [11C]Tetrabenazine and Positron Emission Tomography (1993) (68)
Regional myocardial blood flow, metabolism and function assessed noninvasively with positron emission tomography. (1980) (68)
Striatal presynaptic monoaminergic vesicles are not increased in Tourette’s syndrome (1999) (66)
Imaging local brain function with emission computed tomography. (1984) (66)
Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's disease. (1985) (66)
Similarities of cerebral glucose metabolism in Alzheimer's and Parkinsonian dementia (1985) (65)
Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECT. (1990) (64)
Positron emission computed tomography in the diagnosis of dementia. (1981) (62)
Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: animal localization and initial patient positron emission tomography. (1991) (60)
PET measures of benzodiazepine receptors in progressive supranuclear palsy (2000) (59)
In vivo imaging of the brain vesicular monoamine transporter. (1995) (59)
Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease. (1985) (59)
Dual-[11C]Tracer Single-Acquisition Positron Emission Tomography Studies (2001) (58)
TOMOGRAPHIC MAPPING OF HUMAN CEREBRAL METABOLISM: NORMAL UNSTIMULATED STATE (1981) (57)
Synthesis of 1-[11C]methylpiperidin-4-yl propionate ([11C]PMP) for in vivo measurements of acetylcholinesterase activity. (1998) (55)
An investigation of a double-tracer technique for positron computerized tomography. (1982) (53)
Uneven distribution of maternal and fetal placental blood flow, as demonstrated using macroaggregates, and its response to hypoxia. (1967) (53)
In vivo muscarinic cholinergic receptor imaging in human brain with [11C]scopolamine and positron emission tomography. (1992) (52)
A high-contrast photographic recorder for scintillation counter scanning. (1956) (51)
Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol. (1996) (51)
Correlations of glucose metabolism and structural damage to language function in aphasia (1984) (51)
Tomographic mapping of human cerebral metabolism visual stimulation and deprivation. (1981) (51)
Local cerebral metabolic rates of glucose in movement and language disorders from positron tomography. (1984) (50)
Biodistribution, dosimetry, metabolism and monkey PET studies of [18F]GBR 13119. Imaging the dopamine uptake system in vivo. (1989) (49)
The Mark III Scanner: A Compact Device for Multiple-View and Section Scanning of the Brain1 (1970) (48)
Brain glucose metabolism and memory functions: age decrease in factor scores. (1985) (47)
Mouse brain distribution of a carbon-11 labeled vesamicol derivative: presynaptic marker of cholinergic neurons. (1990) (47)
Determination of regional rate constants from dynamic FDG-PET studies in Parkinson's disease. (1996) (46)
Three-dimensional stereotactic surface projection analysis of macaque brain PET: development and initial applications. (2000) (46)
Neurochemical imaging of Alzheimer's disease and other degenerative dementias. (1998) (45)
Tc-99m dextran: a new blood-pool-labeling agent for radionuclide angiocardiography. (1982) (45)
Synthesis, in vivo biodistribution and dosimetry of [11C]N-methylpiperidyl benzilate ([11C]NMPB), a muscarinic acetylcholine receptor antagonist. (1995) (45)
Discordance between Traditional Pathologic and Energy Metabolic Changes in Very Early Alzheimer's Disease: Pathophysiological Implications (1999) (44)
Radiolabeled Cholinesterase Substrates: In Vitro Methods for Determining Structure-Activity Relationships and Identification of a Positron Emission Tomography Radiopharmaceutical for In Vivo Measurement of Butyrylcholinesterase Activity (2001) (44)
Three-dimensional assessment of myocardial oxidative metabolism: a new approach for regional determination of PET-derived carbon-11-acetate kinetics. (1990) (44)
A theoretical study of quantitative flow measurements with constant infusion of short-lived isotopes. (1979) (44)
Synthesis of [18F]fluoroethoxy-benzovesamicol, a radiotracer for cholinergic neurons (1993) (43)
Quantification of Muscarinic Cholinergic Receptors with [11C]NMPB and Positron Emission Tomography: Method Development and Differentiation of Tracer Delivery from Receptor Binding (1998) (43)
Neuroimaging in Dementia with Lewy Bodies: Metabolism, Neurochemistry, and Morphology (2002) (43)
Pitfalls in the measurement of cerebral blood volume with computed tomography. (1976) (39)
A New Tomograph for Quantitative Positron Emission Computed Tomography of the Brain (1981) (38)
Computed tomography of intracerebral hematomas. II. Radionuclide and transmission CT studies of the perihematoma region. (1977) (37)
Scatter and attenuation correction for brain SPECT using attenuation distributions inferred from a head atlas. (2000) (36)
Mucociliary clearance after lung denervation and bronchial transection. (1972) (36)
Synthesis of the 123I- and 125I-labeled cholinergic nerve marker (-)-5-iodobenzovesamicol. (1993) (32)
Gallium-67 scans in children with solid tumors. (1976) (32)
Crossed cerebellar diaschisis: occurrence and resolution demonstrated with PET during carotid temporary balloon occlusion. (1992) (32)
Scan detection of bone marrow infarcts in sickle cell disorders. (1974) (32)
Characterizing brain lesions with use of transverse section scanning. (1971) (32)
Synthesis of radiolabeled inhibitors of presynaptic monoamine uptake systems; [18F]GBR 13119 (DA),[11C]nisoxetine (NE), and [11C]fluoxetine (5-HT) (1989) (32)
Regional brain metabolism during seizures in humans. (1983) (31)
Transverse section and rectilinear brain scanning with Tc-99-m pertechnetate. (1966) (29)
Anxiety and cerebral cortical metabolism in normal persons (1990) (28)
Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy (1997) (27)
Novel insertional presenilin 1 mutation causing Alzheimer disease with spastic paraparesis (2004) (27)
The brain scan in Sturge-Weber syndrome. (1972) (26)
Measurement of the vital capacity and perfusion of each lung by fluoroscopy and macroaggregated albumin lung scanning. An alternative to bronchospirometry for evaluating individual lung function. (1967) (24)
Stereotaxic Summation Analysis of Human Cerebral Benzodiazepine Binding Maps (1996) (23)
Failure to improve observer performance with scan smoothing. (1972) (22)
LOCAL CEREBRAL BLOOD VOLUME IN HEAD-INJURED PATIENTS. DETERMINATION BY EMISSION COMPUTED TOMOGRAPHY OF 99mTc-LABELED RED CELLS (1980) (21)
99mTc-hexamethylpropyleneamine oxime single photon emission CT in poststroke depression. (1990) (21)
Neurochemical imaging of dementias. (2004) (20)
13N-labeled L-amino acids for in vivo assessment of local myocardial metabolism. (1981) (20)
Evaluating the Performance of Multiplane Positron Tomographs Designed for Brain Imaging (1982) (20)
On the design of capillary and effusive gas dosers for surface science (1995) (20)
Multiple mechanisms for adsorbate-induced resistivity: oxygen and formate on Cu(100) (1997) (19)
In Vivo Quantitation of Regional Myocardial Blood Flow by Positron‐emission Computed Tomography (1981) (19)
Design and application of the MARK IV scanning system for radionuclide computed tomography of the brain (1976) (18)
Neuronal response of the hippocampal formation to injury: Blood flow, glucose metabolism, and protein synthesis (1983) (17)
Coverage-, temperature-, and frequency-dependent broadband infrared reflectance change induced by CO adsorption on Pt(111) (1996) (17)
Initial clinical experience with 18F-2-fluoro-2-deoxy-d-glucose for determination of local cerebral glucose utilization by emission computed tomography. (1977) (17)
Distribution of pulmonary blood flow as affected by transverse (+Gx) acceleration. (1967) (17)
Sensitivity and Resolution in Radioisotope Scanning (1969) (16)
Epileptic patterns of local cerebral metabolism and perfusion in man: investigation by emission computed tomography of 18F-fluorodeoxyglucose and 13N-ammonia. (1978) (16)
SPECT imaging of moyamoya disease using 99mTc-HM-PAO. Comparison with computed tomography findings. (1988) (16)
Design Considerations in Positron Computed Tomography (PCT) (1979) (15)
Positron tomography: "in vivo" autoradiographic approach to measurement of cerebral hemodynamics and metabolism. (1977) (15)
Data Extraction from Brain PET Images Using Three-Dimensional Stereotactic Surface Projections (1998) (15)
Urinary particle dynamics and vesicoureteral reflux in the human. (1970) (14)
Cerebellar metabolic reduction in Alzheimer's disease and data normalization. (1998) (14)
Technetium pertechnetate as a thyroid scanning agent. (1968) (14)
Bone marrow scan evaluation of arthropathy in sickle cell disorders. (1976) (14)
A hybrid processor for modifying and rearranging radionuclide scan data under direct observation. (1969) (14)
INFLUENCE OF COLLIMATOR DESIGN, PHOTON ENERGY AND RADIATION DOSE ON DETECTION EFFECTIVENESS IN LIVER SCANNING. (1965) (14)
Positron computed tomography. (1982) (13)
N-13 Labeled Ammonia and Positron Emission Computerized Axial Tomography (1979) (13)
Comparison of rectilinear vertex and transverse section views in brain scanning. (1970) (13)
Optimizing the window of an Anger camera for 99m Tc. (1971) (13)
Emission Computed Tomography Simulator (1980) (12)
Determinations of cerebral glucose utilization in dementia using positron emission tomography. (1985) (12)
Evidence for a caudate role in aphasia from FDG positron computed tomography (1988) (12)
National Cancer Institute workshop statement: Advances in clinical imaging using positron emission tomography, September 14-16, 1988 (1990) (12)
Transverse-section radionuclide scanning in cisternography. (1976) (11)
Brain Scanning of Children Using Body Section Techniques and Pertechnetate 99mTc (1966) (11)
The use of 99mTc labeled sulfur colloid to study particle dynamics in the urinary tract. Vesicoureteral reflux. (1967) (10)
Positron tomography of the heart. (1980) (10)
The Mark 3 Scanner: a compact device for multiple-view and section scanning of the brain. (1970) (10)
Coexistence curve of perfluoromethylcyclohexane‐isopropyl alcohol (1996) (10)
Cubic Splines for Filter Design in Computed Tomography (1980) (9)
Mapping Local Cerebral Glucose Utilization in Normal Aging and in Cerebrovascular, Degenerative, and Epileptic Disorders (1983) (9)
Brain imaging of glucose utilization in convulsive disorders. (1985) (9)
Technetium-99m-N1-(2-mercapto-2-methylpropyl)-N2-(2-propargylthio-2- methylpropyl)-1,2-benzenediamine (T691): preclinical studies of a potential new tracer of regional cerebral perfusion. (1992) (8)
Rotational scanning of the liver. (1958) (8)
DIGITAL PROCESSING FOR MODIFYING AND REARRANGING RECTILINEAR AND SECTION SCAN DATA UNDER DIRECT OBSERVATION. (1969) (8)
Emission computed tomography in the study of human epilepsy. (1983) (8)
Interpretation of metabolic abnormalities in Alzheimer's disease using three-dimensional stereotactic surface projections (3D-SSP) and normal database (1995) (7)
Brain glucose metabolism in Parkinson's disease. (1990) (7)
Evaluation of methoxytetrabenazine as an in vivo tracer of monoamine nerve terminal integrity. (1994) (6)
Absent splenic uptake of indium-111-oxine-labeled autologous leukocytes in functional asplenia. (1991) (6)
Reduction of presynaptic monoaminergic vesicles in the striata of parkinsonian patients and in normal human aging. (1995) (6)
Giant splenomegaly in sarcoidosis demonstrated by radionuclide scintiphotography. Response to corticosteroid therapy. (1971) (6)
Synthesis and in vivo evaluation of radioiodinated (+)-7- iodobenzovesamicol: A high-affinity ligand for the sigma binding site (1994) (6)
Glucose metabolism of regional myocardial ischemia evaluated by 18fluoro-2-deoxyglucose and positron emission computed tomography (1980) (6)
Epileptic patterns of local cerebral metabolism and perfusion in man determined by emission computed tomography of /sup 18/FDG and /sup 13/NH/sub 3/ (1979) (6)
Blood flow imaging of a posterior circulation stroke. Use of technetium Tc 99m hexamethylpropyleneamine oxime and single photon emission computed tomography. (1988) (6)
The use of (F-18)-Fluorodeoxyglucose Positron Computed Tomography in the Study of Aphasia (1983) (5)
Radiosynthesis and comparisons in the biodistribution of carbon‐11 labeled muscarinic antagonists: (+)2α‐tropanyl benzilate and N‐methyl‐4‐piperidyl benzilate (1989) (5)
The prognostic significance of a deep-wedge pattern in transverse section scanning of cerebral infarctions. (1972) (5)
Simultaneous estimations of blood brain barrier (BBB) permeability and local cerebral blood volume (CBV) in human brain tumors with positron tomography and Ga-68 EDTA (1984) (4)
Dementia: clinical application of positron emission tomography. (1988) (4)
Nuclear Medicine in the 1990 s : The Challenge of Change (4)
Physiologic tomography (PT): a new approach to in vivo measure of metabolism and physiological function. [Diagnostic effectiveness of positron transaxial tomography] (1976) (4)
Non-invasive, long-term, serial studies of rCBF in acute head injury. (1977) (4)
[Integrated and automated data analysis for neuronal activation studies using positron emission tomography: methodology and applications]. (1994) (4)
Methotrexate-Induced Ventriculitis: Appearance on Routine Radionuclide Scan and Emission Computed Tomography (1978) (4)
Early-onset familial Alzheimer's disease and spastic paraparesis associated with a novel insectional mutation of the presenilin 1 gene (2000) (4)
Appendix F: The Non-Prewhitening Matched Filter (NPWMF) (1996) (4)
RELATIONSHIP OF LOCAL CEREBRAL GLUCOSE UTILIZATION AND RELATIVE PERFUSION IN STROKE AND EPILEPSY: DETERMINATION BY EMISSION COMPUTED TOMOGRAPHY OF 18F-FLUORODEOXY-GLUCOSE AND 13N-AMMONIA (1978) (4)
Commonality and differences in aphasia: Evidence from BDAE and PICA (1984) (3)
Distribution of pulmonary blood flow in fetal and newborn lambs. (1970) (3)
Appendix I: Glossary (1996) (3)
CEREBRAL GLUCOSE METABOLISM AS A FUNCTION OF AGE: THE INFLUENCE OF THE RATE CONSTANTS IN THE FDG METHOD (1982) (3)
Validation Of The Noninvasive Tomographic Measure Of Regional Cerebral Glucose Metabolism In Man With 18f-2-fluoro-2-deoxy-glucose (1978) (3)
Positron emission tomography of the heart (1979) (3)
Radionuclide computerized tomography for brain study (1975) (3)
Kinetic evaluation of [C-11]dihydrotetrabenazine (DTBZ) by dynamic PET : a marker for the vesicular monoamine transporter. (1995) (3)
Evaluation of myocardial blood flow and metabolism using positron emission tomography (1989) (3)
Human cerebral metabolism studied during limitation in sensory inputs. (1981) (2)
COMPARISON WITH COMPUTED TOMOGRAPHY FINDINGS (1988) (2)
Brain Scan in Sturge-Weber Syndrome (1971) (2)
Design and performance characteristics of the ECAT positron tomograph (1978) (2)
Interpretation of Regional Neurochemical and Anatomic Changes in Neurodegeneration: Multivariate Approach (1998) (2)
Relationship of local cerebral glucose utilization and perfusion in brain ischemia: Determination by emission computed tomography of (F-18) fluorodeoxyglucose and (N-13) ammonia (1978) (2)
Principles of radionuclide emission imaging (1983) (2)
In Vivo Studies of Acetylcholinesterase Activity Using a Labeled Substrate , N-[ WIMethylpiperdin-4-yl Propionate (2004) (2)
6. Future Work (1996) (2)
metabolism in Normal (1990) (2)
Perforated tape recorder for digital scan data store with grey shade and numeric readout. (1966) (2)
PET with F-18 fluorodeoxyglucose measures of local brain activity and memory in schizophrenia and in depression (1984) (1)
Validation of the non-invasive tomographic measure of regional cerebral glucose metabolism in man with [F-18]2-fluoro-2-deoxyglucose (1978) (1)
Frontal hypometabolism in mild Alzheimer's disease is associated with more rapid progression of dementia (2000) (1)
Kinetic evaluation of [C-11] dihydrotetrabenazine : a PET ligand for assessing the vesicular monoamine transporter. (1995) (1)
The urinary particle scan: a tracer technique for determination of bladder bacterial residual. (1972) (1)
COMPUTER PROCESSING OF IMAGES IN NUCLEAR MEDICINE. (1970) (1)
Radiopharmaceuticals for diagnosis and treatment (1991) (1)
Tc-99m DEXTRAN: A NEW AGENT FOR LYMPHOSCINTIGRAPHY (1981) (1)
Alzheimer's and Parkinson's disease dementia with similar dementia severity compared with the FDG-PET method (1995) (1)
High-level production and use of carbon-11: A strategy for containment of stack emissions (1994) (1)
Summary of discussion: Positron emission tomography of abnormal and diseased states, I (1984) (1)
Appendix D: Examples of the Application of the Ideal Observer to Medical Imaging (1996) (1)
Is regional glucose metabolism different between Alzheimer’s and Parkinson’s disease dementia with similar dementia severity ? (1995) (1)
Usefulness of [18F]-deoxyglucose local metabolic rates in aphasia. (1979) (1)
Limitations of Orthogonal Tangent Correction—The Authors' Reply (1974) (1)
4. Quality of the Observed Image (1996) (1)
Emission computerized-tomography and determination of local brain function (1975) (1)
5. Measurement of Image Quality Parameters (1996) (0)
Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington??s disease (1987) (0)
Application of the ''bootstrap'' technique to understanding cerebral interregional metabolic relationships (1984) (0)
New approaches to image formation in radioisotope scanning. Progress report, August 1, 1972--April 27, 1973 (1973) (0)
Fine Grained Neural Network Classification of Positron Emission Tomography Scans of Alzheimer's and Normal Subjects (1998) (0)
Glucose metabolic imaging for functional diagnosis of brain disorders; current status and prospects (1998) (0)
Radiopharmaceuticals for diagnosis (1990) (0)
Appendix E: The Hotelling Observer (1996) (0)
3. Quality of the Acquired Data (1996) (0)
ICRU Reports (1996) (0)
Development of scan analysis techniques employing a small computer. Progress report, August 1, 1973--July 31, 1974 (1974) (0)
Posterior cortical hypometabolism precedes mixed subcortical-cortical metabolic changes in incident dementia in Parkinson disease (2008) (0)
RADIOIODINE SCANNING IN DISEASES OF THE THYROID GLAND (1963) (0)
Older age of Parkinson's disease onset associated with increased cognitive impairment, even in patients without dementia (1999) (0)
New techniques for positron emission tomography in the study of human neurological disorders (1992) (0)
Radiopharmaceuticals for diagnosis and treatment. Progress report (1991) (0)
Emission computed tomography: a new technique for the quantitative physiologic study of brain and heart in vivo (1978) (0)
EVALUATION OF BLOOD BRAIN BARRIER PERMEABILITY IN HUMAN BRAIN TUMORS WITH POSITRON TOMOGRAPHY AND Ga‐68 EDTA.: H8 (1983) (0)
Investlg atlon of [ â€˜8 F] 2- Fluoro-2--Deoxyglu cose for the Measure of Myocardlal Glucose Metabolism (2006) (0)
Current BER Scientists: Principal Investigators (2001) (0)
Appendix C: The Ideal Bayesian Observer (1996) (0)
Dr. Kling and Associates Reply (1987) (0)
Cognitive correlates of posterior cingulate hypometabolism in Parkinson disease (2008) (0)
Brain metabolism and memory in age differentiated healthy adults (1984) (0)
Measurement of Amino Acid Uptake and Distribution V olume in Human Brain (1990) (0)
2. Present Approaches to Measuring Image Quality Parameters (1996) (0)
Synthesis of the 1231- and 1251-labeled Cholinergic Nerve Marker ( - )-5Iodobenzovesamicol* (1993) (0)
in Normal &ng, AlzheimJs Disease, and Parlunson's Disease (1996) (0)
クール博士 Japan Prize 受賞記念講演テキスト A slice of life: 50 years of emission tomography (Japan Prize) (2009) (0)
Local cerebral glucose utilization measured with 18F-2-fluoro-2-deoxyglucose (1978) (0)
Relationship of brain imaging with radionuclides and with x-ray computed tomography (1981) (0)
Cardiovascular nuclear medicine 1980 (1980) (0)
Executive Summary (1996) (0)
1. General Introduction (1996) (0)
Restoration of Brain Cholinergic Synaptic Density by Long-Term Postmenopausal Estrogen Replacement (1998) (0)
Evidence for a caudate role in aphasia from FDG positron emission tomography (1982) (0)
Appendix G: Models of the Human Observer (1996) (0)
anatomical assessment system by using the cross-sections of emission decay of radionuclides (1976) (0)
Appendix H: Estimation (1996) (0)
Development of scan analysis techniques employing a small computer. Progress report, August 1, 1974--July 31, 1975 (1975) (0)
ESTIMATION AND LOCALIZATION OF PULMONARY VASCULAR ABNORMALITIES USING RADIOISOTOPE SCANNING (1967) (0)
Nitrogen-13-labeled L-amino acids for in vivo assessment of local myocardial metabolism (1981) (0)
Evaluation of Extrastriatal Specific Binding of [11C]Dihydrotetrabenazine Using Active and Inactive Enantiomers (2001) (0)
In Vivo Mapping of Cholmergic Termina in Normal & ng , Alzheimer ' s Disease , and Parlunson ' s Disease l eri (0)
Comparison of cerebral regional glucose metabolic relationships in resting and auditory stimulated states (1984) (0)
Imaging with the Mark IV (1977) (0)
Discrepancy between thallium-201 redistribution and rubidium-82 blood flow imaging (1990) (0)
Positron computed tomography: current state, clinical results and future trends (1980) (0)
Reply (1983) (0)
Control of oxidative degradation in 99mTc-labeled ferrous hydroxide: a simplified method. (1971) (0)
Advancing PET science for new measures of brain function. Progress report, January 1, 1994--December 31, 1994 (1994) (0)
Quantitative section scanning in evaluation of local cerebal vasculature (1974) (0)
Selective uptake of radionuclides as a basis for tumor detection. (1969) (0)
42. Restoration of brain cholinergic synaptic density by long-term postmenopausal estrogen replacement (1998) (0)
Development of scan analysis techniques employing a small computer. Final report, February 1, 1963--July 31, 1976 (1976) (0)
Appendix A: Medical Imaging Devices (1996) (0)
Measurement of regional cerebral metabolic rate for glucose in the human subject with (F-18)-2-deoxy-2-fluoro-d-glucose and emission computed tomography: validation of the method (1977) (0)
Reply (0)
New techniques for positron emission tomography in the study of human neurological disorders. Progress report, June 1990--June 1993 (1993) (0)
Appendix B: Image Degradation (1996) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With David E. Kuhl?

David E. Kuhl is affiliated with the following schools:

David E. Kuhl's Academic­Influence.com Rankings

Why Is David E. Kuhl Influential?

David E. Kuhl's Published Works

Published Works

What Schools Are Affiliated With David E. Kuhl?

David E. Kuhl's AcademicInfluence.com Rankings